Emily Stephenson on Muck Rack

Emily Stephenson

As seen in: The Assembly, MSN, UOL Notícias, Business Insider, Color Research & Application, Daily Mail, HuffPost, Nature, Reuters, The Daily Mirror, The Independent (UK) and
Managing editor @theassemblync. @wsj, @politico, @Reuters alum. Tar Heel. Make your free throws.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Emily

Contact Emily, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha.

|
By Kirsty Hodgson, Gary Reynolds, Emily Stephenson, Joseph Inns
| biorxiv.org
Abstract CYLD cutaneous syndrome (CCS) skin tumors develop from puberty onwards, can number in the hundreds and progressively grow over time. CCS patients lack medical therapies and require repeated surgery to control tumor burden. CYLD loss of heterozygosity (LOH) drives tumor growth, and CCS tumors have previously been shown to demonstrate increased canonical NF-κB and Wnt signalling.
Open in Who Shared Issue with article?

N.C. Lawmaker Says "Emergency is Still in Place" After Helene

|
By Emily Stephenson
| The Assembly Verified
The state legislature last week unanimously passed a $273 million package aimed at providing relief to Western North Carolina after the devastation caused by Hurricane Helene. Lawmakers said it’s only the first round of disaster spending, with more expected as they determine what’s needed. In addition to funds for state agencies, the legislation gives schools more flexibility over their calendars and allows 25 western counties to adjust polling sites and make other election-related changes.
Open in Who Shared Issue with article?

Temporal multi-omic analysis of COVID-19 in end-stage kidney disease

|
By Emily Stephenson, Erin Macdonald-Dunlop, Lisa M Dratva, Rik G.H. Lindeboom
| medRxiv
S.A.T is on the advisory board for Cell Genomics. L.M.D., R.G.H.L. and S.A.T. are inventors on a filed patent that is related to the detection and application of activated T cells. In the past three years, S.A.T. has received remuneration for Scientific Advisory Board Membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and holds equity in Transition Bio and Ensocell. From 8 January 2024, S.A.T is a part-time employee of GlaxoSmithKline.
Open in Who Shared Issue with article?
See all 1,432 licensed articles (2,264 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified